PRKACA and neoplasm: In wild-type mice, loss of both Prkaca and Prkacb led to slower tumor growth and significant extension of host survival in comparison to tumors with two NTC sgRNAs, or single sgRNA targeting Prkaca or Prkacb (Fig. 6E and Supplementary Fig. S9B).